Back to Search
Start Over
Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study
- Source :
- Journal of The American Academy of Dermatology, Journal of The American Academy of Dermatology, Elsevier, 2018, 79 (1), pp.162-165. ⟨10.1016/j.jaad.2018.02.049⟩
- Publication Year :
- 2018
- Publisher :
- HAL CCSD, 2018.
-
Abstract
- International audience
- Subjects :
- Adult
Male
medicine.medical_specialty
Dermatology
Risk Assessment
Severity of Illness Index
Drug Administration Schedule
Cohort Studies
Hospitals, University
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
Age Distribution
Thromboembolism
Severity of illness
Lupus Erythematosus, Cutaneous
Medicine
Humans
Sex Distribution
Survival rate
ComputingMilieux_MISCELLANEOUS
Aged
Retrospective Studies
030203 arthritis & rheumatology
Lupus erythematosus
Dose-Response Relationship, Drug
business.industry
Incidence (epidemiology)
Incidence
Retrospective cohort study
Middle Aged
medicine.disease
3. Good health
Thalidomide
Survival Rate
Female
France
business
Risk assessment
Immunosuppressive Agents
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Cohort study
medicine.drug
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 01909622 and 10976787
- Database :
- OpenAIRE
- Journal :
- Journal of The American Academy of Dermatology, Journal of The American Academy of Dermatology, Elsevier, 2018, 79 (1), pp.162-165. ⟨10.1016/j.jaad.2018.02.049⟩
- Accession number :
- edsair.doi.dedup.....8521d91f8033398f24e68407bd9a86f3